Robotic apparel to help prevent freezing of gait in Parkinson's disease

Preventing Freezing of Gait in Parkinson's Disease Using Soft Robotic Apparel

NA · Harvard Medical School (HMS and HSDM) · NCT06602544

This study is testing if soft robotic clothing can help people with Parkinson's disease walk better and reduce episodes of freezing while they move.

Quick facts

PhaseNA
Study typeInterventional
Enrollment20 (estimated)
Ages18 Years to 90 Years
SexAll
SponsorHarvard Medical School (HMS and HSDM) (other)
Locations2 sites (Allston, Massachusetts and 1 other locations)
Trial IDNCT06602544 on ClinicalTrials.gov

What this trial studies

This study investigates the use of soft robotic apparel to assist individuals with Parkinson's disease who experience freezing of gait (FoG). It aims to understand how mechanical assistance can improve gait mechanics and reduce the frequency and severity of FoG episodes. Through a series of controlled laboratory experiments, the study will assess the effectiveness of the robotic apparel in various walking conditions and measure its impact on gait parameters. Participants will undergo multiple visits to evaluate the performance of the robotic device in preventing FoG.

Who should consider this trial

Good fit: Ideal candidates include individuals aged 18-90 with self-reported freezing of gait due to Parkinson's disease who can walk independently.

Not a fit: Patients who have experienced more than two falls in the previous month or have significant gait deficits due to missing limbs may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve mobility and quality of life for patients with Parkinson's disease by reducing episodes of freezing of gait.

How similar studies have performed: Other studies have shown promise in using robotic assistance for gait improvement in neurological populations, indicating potential for success in this novel approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-90 years old
* Self-reported Freezing of Gait due to PD
* Score of 21 or higher on the cognitive screening test (Montreal Cognitive Assessment Score (MoCA))
* Independent ambulation (with or without an assistive device, no physical assistance) for at least 20 meters
* Able to understand, communicate, and be understood by study staff
* Provide HIPAA Authorization to allow communication with the participant's treating physician/provider for medical clearance (if deemed necessary by study clinical team) to verify self-reported medical history (if deemed necessary by study clinical team)
* Provide informed consent
* Ability to participate in 8 research study visits

Exclusion Criteria:

* More than 2 falls in the previous month, as a result of gait impairment (may enroll under clinician discretion)
* Major surgery in the last 6 months that interferes with walking (may enroll under clinician discretion)
* Gait deficits due to missing limbs
* Experience chronic pain that interferes with walking ability (may enroll under clinician discretion)
* Serious co-morbidities (unrelated to gait impairment) that may interfere with ability to participate in research (e.g. cardiovascular, neurological, skin, and vascular conditions such as acute, ongoing/unmanaged deep vein thrombosis)
* No observable freezing-of-gait

Where this trial is running

Allston, Massachusetts and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Parkinson Disease, Freezing-of-gait, Wearable Robot, Soft Robotics, Gait, Rehabilitation

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.